RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 171 filers reported holding RELAY THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.11 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $41,264,413 | -54.4% | 4,906,589 | -32.0% | 0.00% | -60.0% |
| Q2 2023 | $90,567,610 | -6.5% | 7,210,797 | +22.6% | 0.01% | 0.0% |
| Q1 2023 | $96,848,228 | -48.3% | 5,880,281 | -53.1% | 0.01% | 0.0% |
| Q4 2022 | $187,183,170 | +128.1% | 12,528,994 | +241.6% | 0.01% | 0.0% |
| Q3 2022 | $82,055,000 | +2.5% | 3,668,070 | -23.2% | 0.01% | 0.0% |
| Q2 2022 | $80,039,000 | -17.8% | 4,778,419 | +46.9% | 0.01% | 0.0% |
| Q1 2022 | $97,383,000 | -0.5% | 3,253,692 | +2.1% | 0.01% | 0.0% |
| Q4 2021 | $97,858,000 | +15.7% | 3,186,522 | +18.8% | 0.01% | +25.0% |
| Q3 2021 | $84,553,000 | +4.2% | 2,681,676 | +20.9% | 0.00% | 0.0% |
| Q2 2021 | $81,162,000 | +16.5% | 2,218,160 | +10.1% | 0.00% | 0.0% |
| Q1 2021 | $69,678,000 | +26.4% | 2,015,576 | +51.9% | 0.00% | +33.3% |
| Q4 2020 | $55,138,000 | +170.9% | 1,326,705 | +177.6% | 0.00% | +200.0% |
| Q3 2020 | $20,353,000 | – | 477,888 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 10,551,115 | $438,504,000 | 37.66% |
| TRV GP IV, LLC | 2,811,197 | $116,833,000 | 37.48% |
| Foresite Capital Management V, LLC | 400,000 | $16,624,000 | 12.31% |
| Foresite Capital Management IV, LLC | 2,139,380 | $88,913,000 | 9.66% |
| EcoR1 Capital, LLC | 3,200,649 | $133,019,000 | 7.15% |
| BVF INC/IL | 3,073,147 | $127,720,000 | 5.02% |
| Casdin Capital, LLC | 3,808,894 | $158,298,000 | 4.69% |
| SB INVESTMENT ADVISERS (UK) LTD | 27,904,963 | $1,159,730,000 | 4.67% |
| Grace Capital | 164,389 | $6,832,000 | 4.32% |
| Alphabet Inc. | 1,801,490 | $74,870,000 | 3.59% |